- Home
- GSIW vs PALI Comparison
GSIW vs PALI Comparison
Compare GSIW & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- PALI
- Stock Information
- Founded
- GSIW 2016
- PALI 1996
- Country
- GSIW Hong Kong
- PALI United States
- Employees
- GSIW N/A
- PALI N/A
- Industry
- GSIW
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GSIW
- PALI Health Care
- Exchange
- GSIW Nasdaq
- PALI Nasdaq
- Market Cap
- GSIW 8.1M
- PALI 7.5M
- IPO Year
- GSIW 2023
- PALI N/A
- Fundamental
- Price
- GSIW $0.10
- PALI $0.75
- Analyst Decision
- GSIW
- PALI Strong Buy
- Analyst Count
- GSIW 0
- PALI 2
- Target Price
- GSIW N/A
- PALI $12.00
- AVG Volume (30 Days)
- GSIW 9.2M
- PALI 5.4M
- Earning Date
- GSIW 01-01-0001
- PALI 08-11-2025
- Dividend Yield
- GSIW N/A
- PALI N/A
- EPS Growth
- GSIW N/A
- PALI N/A
- EPS
- GSIW N/A
- PALI N/A
- Revenue
- GSIW $5,368,221.00
- PALI N/A
- Revenue This Year
- GSIW N/A
- PALI N/A
- Revenue Next Year
- GSIW N/A
- PALI N/A
- P/E Ratio
- GSIW N/A
- PALI N/A
- Revenue Growth
- GSIW 283.23
- PALI N/A
- 52 Week Low
- GSIW $0.09
- PALI $0.60
- 52 Week High
- GSIW $12.30
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- GSIW 20.06
- PALI 42.17
- Support Level
- GSIW $0.09
- PALI $0.70
- Resistance Level
- GSIW $0.13
- PALI $0.85
- Average True Range (ATR)
- GSIW 0.01
- PALI 0.14
- MACD
- GSIW 0.04
- PALI -0.02
- Stochastic Oscillator
- GSIW 28.00
- PALI 7.58
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.